Antibiotic-free selection in E. coli: new considerations for optimal design and improved production
Tóm tắt
The increasing regulatory requirements to which biological agents are subjected will have a great impact in the field of industrial protein expression and production. There is an expectation that in a near future, there may be "zero tolerance" towards antibiotic-based selection and production systems. Besides the antibiotic itself, the antibiotic resistance gene is an important consideration. The complete absence of antibiotic-resistance gene being the only way to ensure that there is no propagation in the environment or transfer of resistance to pathogenic strains. In a first step, we have designed a series of vectors, containing a stabilization element allowing a complete elimination of antibiotics during fermentation. Vectors were further improved in order to include alternative selection means such as the well known poison/antidote stabilization system. Eventually we propose an elegant positive pressure of selection ensuring the elimination of the antibiotic-resistance gene through homologous recombination. In addition, we have shown that the presence of an antibiotic resistance gene can indirectly reduce the amount of expressed protein, since even in absence of selection pressure the gene would be transcribed and account for an additional stress for the host during the fermentation process. We propose a general strategy combining plasmid stabilization and antibiotic-free selection. The proposed host/vector system, completely devoid of antibiotic resistance gene at the end of construction, has the additional advantage of improving recombinant protein expression and/or plasmid recovery.
Tài liệu tham khảo
Gerdes K, Rasmussen PB, Molin S: Unique type of plasmid maintenance function: postsegregational killing of plasmid-free cells. Proc Natl Acad Sci USA. 1986, 83: 3116-20. 10.1073/pnas.83.10.3116.
Handa N, Kobayashi I: Post-segregational killing by restriction modification gene complexes: observations of individual cell deaths. Biochimie. 1999, 81 (8): 931-938. 10.1016/S0300-9084(99)00201-1.
Degryse E: Stability of a host-vector system based on complementation of an essential gene in Escherichia coli. J Biotechnol. 1991, 18: 29-39. 10.1016/0168-1656(91)90233-L.
Cranenburgh RM, Hanak JA, Williams SG, Sherratt DJ: Escherichia coli strains that allow antibiotic-free plasmid selection and maintenance by repressor titration. Nucleic Acids Res. 2001, 29: E26- 10.1093/nar/29.5.e26.
Hagg P, de Pohl JW, Abdulkarim F, Isaksson LA: A host/plasmid system that is not dependent on antibiotics and antibiotic resistance genes for stable plasmid maintenance in Escherichia coli. J Biotechnol. 2004, 111: 17-30. 10.1016/j.jbiotec.2004.03.010.
Fiedler M, Skerra A: ProBA complementation of an auxotrophic E. coli strain improves plasmid stability and expression yield during fermenter production of a recombinant antibody fragment. Gene. 2001, 274: 111-8. 10.1016/S0378-1119(01)00629-1.
Vidal L, Pinsach J, Striedner G, Caminal G, Ferrer P: Development of an antibiotic-free plasmid selection system based on glycine auxotrophy for recombinant protein overproduction in Escherichia coli. J Biotechnol. 2008, 134: 127-36. 10.1016/j.jbiotec.2008.01.011.
Pfaffenzeller I, Mairhofer J, Striedner G, Bayer K, Grabherr R: Using ColE1-derived RNA I for suppression of a bacterially encoded gene: implication for a novel plasmid addiction system. Biotechnol J. 2006, 1: 675-81. 10.1002/biot.200600017.
Mairhofer J, Pfaffenzeller I, Merz D, Grabherr R: A novel antibiotic free plasmid selection system: advances in safe and efficient DNA therapy. Biotechnol J. 2008, 3: 83-9. 10.1002/biot.200700141.
Luke J, Carnes AE, Hodgson CP, Williams JA: Improved antibiotic-free DNA vaccine vectors utilizing a novel RNA based plasmid selection system. Vaccine. 2009, 27: 6454-6459. 10.1016/j.vaccine.2009.06.017.
Goh S, Good L: Plasmid selection in Escherichia coli using an endogenous essential gene marker. BMC Biotechnol. 2008, 11: 61-10.1186/1472-6750-8-61. 10.1186/1472-6750-8-61.
Soubrier F, Cameron B, Manse B, Somarriba S, Dubertret C, Jaslin G, Jung G, Caer CL, Dang D, Mouvault JM, Scherman D, Mayaux JF, Crouzet J: pCOR: a new design of plasmid vectors for nonviral gene therapy. Gene Ther. 1999, 6: 1482-8. 10.1038/sj.gt.3300968.
Szpirer CY, Milinkovitch MC: Separate-component-stabilization system for protein and DNA production without the use of antibiotics. Biotechniques. 2005, 38: 775-81. 10.2144/05385RR02.
Palmeros B, Wild J, Szybalski W, Le Borgne S, Hernández-Chávez G, Gosset G, Valle F, Bolivar F: A family of removable cassettes designed to obtain antibiotic-resistance-free genomic modifications of Escherichia coli and other bacteria. Gene. 2000, 247: 255-64. 10.1016/S0378-1119(00)00075-5.
Datsenko KA, Wanner BL: One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA. 2000, 97: 6640-5. 10.1073/pnas.120163297.
Mizoguchi H, Tanaka-Masuda K, Mori H: A simple method for multiple modification of the Escherichia coli K-12 chromosome. Biosci Biotechnol Biochem. 2007, 71: 2905-11. 10.1271/bbb.70274.
Summers DK, Sherratt DJ: Multimerization of high copy number plasmids causes instability: CoIE1 encodes a determinant essential for plasmid monomerization and stability. Cell. 1984, 36: 1097-103. 10.1016/0092-8674(84)90060-6.
Balding C, Blaby I, Summers DA: Mutational analysis of the ColE1-encoded cell cycle regulator Rcd confirms its role in plasmid stability. Plasmid. 2006, 56: 68-73. 10.1016/j.plasmid.2005.12.001.
Stirling CJ, Stewart G, Sherratt DJ: Multicopy plasmid stability in Escherichia coli requires host-encoded functions that lead to plasmid site-specific recombination. Mol Gen Genet. 1988, 214: 80-4. 10.1007/BF00340183.